Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH/Nrf2 pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39121729.
- Also identified by DOI 10.1016/j.biomaterials.2024.122707.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polypyrimidine tract-binding protein 1 (PTBP1) regulates numerous alternative splicing events during tumor progression and neurogenesis. Previously, PTBP1 downregulation was reported to convert astrocytes into functional neurons; however, how PTBP1 regulates astrocytic physiology remains unclear. In this study, we revealed that PTBP1 modulated glutamate uptake via ATP1a2, a member of Na<sup>+</sup>/K<sup>+</sup>-ATPases, and glutamate transporters in astrocytes. Ptbp1 knockdown altered mitochondrial function and energy metabolism, which involved PTBP1 regulating mitochondrial redox homeostasis via the succinate dehydrogenase (SDH)/Nrf2 pathway. The malfunction of glutamate transporters following Ptbp1 knockdown resulted in enhanced excitatory synaptic transmission in the cortex. Notably, we developed a biomimetic cationic triblock polypeptide system, i.e., polyethylene glycol<sub>44</sub>-polylysine<sub>30</sub>-polyleucine<sub>10</sub> (PEG<sub>44</sub>-PLL<sub>30</sub>-PLLeu<sub>10</sub>) with astrocytic membrane coating to deliver Ptbp1 siRNA in vitro and in vivo, which approach allowed Ptbp1 siRNA to efficiently cross the blood-brain barrier and target astrocytes in the brain. Collectively, our findings suggest a framework whereby PTBP1 serves as a modulator in glutamate transport machinery, and indicate that biomimetic methodology is a promising route for in vivo siRNA delivery.
Medical subject headings
- Astrocytes
- Glutamic Acid
- Polypyrimidine Tract-Binding Protein
- Homeostasis
- RNA, Small Interfering
- NF-E2-Related Factor 2
- Heterogeneous-Nuclear Ribonucleoproteins